Psycho(patho)logy of addicton: An interpretative model;Psico(pato)logia dell' "addiction". Un'ipotesi interpretativa

Annali dell'Istituto Superiore di Sanita

Volumn 38, Issue 3, 2002, Pages 241-257

  Maremmani, Icro ^a   Canoniero, Stefania ^a   Pacini, Matteo ^a  

^a NONE

Author keywords

Addiction; Addictive personality; Mood disorders; Personality

Indexed keywords

METHADONE; NALOXONE;

ADDICTION; ATTITUDE; CLINICAL FEATURE; COMORBIDITY; CONFERENCE PAPER; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG DEPENDENCE; ENVIRONMENTAL FACTOR; HUMAN; MENTAL DISEASE; MODEL; MOOD DISORDER; PATHOGENESIS; PERSONALITY; SELF MEDICATION; SUBSTANCE ABUSE; HIGH RISK BEHAVIOR; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW;

HUMANS; RISK-TAKING; SUBSTANCE-RELATED DISORDERS;

EID: 0036961783     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (160)

1. Wikler A. A theory of opioid dependence. In: Lettieri DJ, Sayers M, Pearson HW (Ed.). Theories on drug abuse. Selected contemporary perspectives. Rockville: NIDA; 1980. (Nida Research Monograph, 30). p. 174-8.
2. Khantzian EJ. An ego/self theory of substance dependence: a contemporary psychoanalitic perspective. In: Lettieri DJ, Sayers M, Pearson HW (Ed.). Theories on drug abuse. Selected contemporary perspectives. Rockville: NIDA; 1980. (Nida Research Monograph, 30). p. 184-91.
3. Dole VP. Nyswander ME. Heroin addiction: A metabolic disease. Arch Intern Med 1967;120:19-24.
4. Mc Kenna GJ. Methadone and opiate drugs: psychotropic effects and self medication. In: Verebey K (Ed.). Opioids in mental illness. New York: New York Academy of Science; 1982. p. 33-43.
5. Maremmani I, Zolesi O, Cirillo M, Tagliamonte A, Castrogiovanni P. Ai confini dei disturbi dell'umore: la tossico-dipendenza da eroina come autoterapia. In: Placidi GF, Dell'Osso L, Canova LM (Ed.). 1 confini dei disturbi dell'umore. Pisa: SEU; 1992. p. 283-90.
6. Haddox V, Jacobson M. Psychological adjustment, mood and personality fluctuations in long term methadone maintenance patients. Int J Addict 1972;7:619-27.
7. Korin H. Comparison of psychometric measures in psychiatric patients using heroin and other drugs. J Abnorm Psychol 1974;83:208-12.
8. Nisle A, Robinowitz R, Penk JR. An empirical test of anhedonia in compulsive use of illicit drugs. Dallas. Texas: VAMC, Drug Abuse Program; 1979.
9. Platt JJ, Scurra W. Peer adjustement of parole success in institutionalized heroin addicts: personality correlates and validity. J Consult Clin Psychol 1975;21:511-5.
10. Reid WH. The psychopathology: a comprehensive study of antisocial disorders and behavior. New York: Wiley; 1978.
11. Craig RJ. Personality characteristics of heroin addicts. A review of the empirical literature with critique. Part II. Int J Addict 1979;14:607-26.
12. Burger GK, Collins HA. Relationship between MMPI and CPI Types of Male Heroin Abusers. Am J Drug Alcohol Abuse 1982; 9:281-7.
13. Kurtines W, Hogan R, Weiss D. Personality dynamic of heroin use. J Abnorm Psychol 1975;84:87-9.
14. Martin J, Ingles J. Pain tolerance and narcotic addiction. Br J Soc Psychol 1965;4:224-9.
15. Roehric H, Gold MS. Diagnosis of substance abuse in an adolescent psychiatric population. Int J Psychiatry Med 1986;16/2:137-43.
16. McLellan AT, Woody GE, O'Brien CP. Development of psychiatric illness in drug abusers: Possible role of drug preference. N Engl J Med 1979;301:1310-4.
17. Dorus W, Senay EC. Depression demographic dimensions, and drug abuse. Am J Psychiatry 1980;137:669-704.
18. Steer RA, Schut J. Affect dimension of male heroin addicts admitted for inpatient detoxification. Int J Addict 1981;1:341-8.
19. Jacobs PE, Doft EB, Koger J. A study of SCL-90 scores of 264 methadone patients in treatment. Int J Addict 1981;16:541-8.
20. Maremmani I, Daini L. Sintomi di Comorbidità Psichiatrica durante il trattamento della dipendenza da eroina. Boll Farmacodip e Alcoolis 2000;23(1):29-38.
21. Rothaizer JM. Typological study of substance abusers using the MMPI. J Clin Psychol 1980;36:1019-21.
22. Penk WE. Assessing the substance abuser with the MMPI. Clinical notes on the MMPI. Nutley: La Roche; 1981.
23. Penk WE, Robinowitz R, Roberts M. MMPI difference of male hispanic-american, black and white heroin addicts. J Counsult Clini Psychology 1981;49:488-90.
24. Penk WE, Robinowitz R. Personality differences of heroin addicts and polydrug abusers. In: Craig R, Baker S (Ed.). Drug dependent patients: treatment and research. Springfield: Charles Thomas; 1982. p. 187-219.
25. Esbaugh DM, Dick KV, Tori DJ. Typological analysis of MMPI personality patterns of drug dependent females. J Pers 1982;46:488-94.
26. De Leon G, Rosenthal M, Brodney K. Therapeutic Community for drug addicts, long term measurement of emotional changes. Psychol Rep 1971;29:595-600.
27. De Leon G, Skodon A, Rosenthal MS. Phoenix House. Changes in Psychopatology signs of resident drug addicts. Arch Gen Psychiatry 1973;28:131-5.
28. De Leon G, Jainchill N. Male and Female drug abusers: serial and psychological status 2 years after treatment in a therapeutic community. Am J Drug Alcohol Abuse 1981;8/4:465-97.
29. De Leon G, Wexler HK, Jainchill N. The therapeutic community: success and improvement rates 5 years after treatment. Int J Addict 1982;17/4:703-47.
30. Lefcourt HM, Telegdi MS. Perceived locus of control and field dependence as predictors of cognitive activity. J Consult Clin Psychol 1971:37(1):53-6.
31. Webster RA, Hunter M, Keats JA. Personality and sociodemographic influences on adolescent's substance use: a path analysis. Int J Addict 1994;29(7):941-56.
32. Felix RH. An appraisal of the personality types of the addict. Am J Psychiatry 1944;100:462-0.
33. Glover E. On the etiology of drug addiction (1932). In: Glover E (Ed.). On the early development of the mind. New York: International Universities Press; 1956. p. 187-215.
34. Cerquetelli G. La clinica psichiatrica oggi: il sé e gli stati limite. Clin Psichiat 1980;16:9-110.
35. Kernberg O. Sindromi marginali e narcisismo patologico. Torino: Boringhieri; 1978.
36. Kolb LC. Types and characteristics of drug addicts. Ment Hyg 1925;9:300-13.
37. A.P.A. DSM-III Diagnostic and statistical manual. 3d ed. Washington DC: American Psychiatric Association; 1980.
38. Clerici M, Carta I, Cazzullo CL. Substance abuse and psychopathology: a diagnostic screening of Italian narcotic addicts. Soc Psych 1989;24:219-26.
39. Mezzich JE, Ahn CW, Fabrega H. Patterns of psychatric Comorbidity in a large popuation presenting for care. In: Maser JD, Cloninger CR (Ed.). Comorbidity of mood and anxiety disorders. Washington: American Psychiatric Press; 1990.
40. Arntz A, Merckelbach H, De Jong P. Opioid antagonist affects behavioral effects of exposure in vivo. J Consult Clin Psychol 1993;61:865-70.
41. Skodol A.E., Oldham JM, Gallagher PE. Axis II comorbidity of substance abuse disorders among patients referred for treatment of personality disorders. Am J Psychiatry 1999;156:733-8.
42. Khantzian EJ, Treece C. DSM-III psychiatric diagnosis of narcotic addicts: Recent findings. Arch Gen Psychiatry 1985;42:1067-77.
43. Nace EP. Personality disorder in the alcoholic patient. Psychiat Ann 1990;19:256-60.
44. Kosten TR, Rounsaville J, Kleber HB. DSM III Personality Disorders in opiate addicts. Compr Psychiatry 1982;23:572-81.
45. Kraepelin E. Maniac-depressive illness and paranoia. Edinburgh: Livingstone; 1921.
46. Kleinman PH, Miller AB, Woody GE. Psychopatology among cocaine abusers entering in treatment. J Nerv Ment Dis 1990;178:442-7.
47. Zimmerman M, Coryell W. DSM-III Personality disorder diagnoses in a non patient sample: demographic correlates and comorbidity. Arch Gen Psychiatry 1989;46:682-9.
48. Dulit RA, Fyer MR, Haas GL, Sullivan T, Frances AJ. Substance use in borderline personality disorders. Am J Psychiatry 1990;147:1002-7.
49. Yates WR, Fulton AI, Gabel JM, Brass CT. Personality risk factors for cocaine abusers. Am J Public Health 1989;79(7):891-2.
50. Grande TP, Wolf AW, Schubert DSP, Patterson MP, Brocco K. Association among alcoholism, drug use and antisocial personality: a review of the literature. Psychol Rep 1984;55:455-74.
51. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LJ, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiological Catchment Area (ECA) study. JAMA 1990;264:2511-8.
52. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HVKHS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity study. Arch Gen Psychiatry 1994;51:8-19.
53. Ross HE, Glasser FB, Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry 1988;45:1023-32.
54. Atkinson JH, Schuckit MA. Geriatric alcohol and drug misuse and abuse. Adv Substance Ab 1983;3:195-237.
55. Luthar SS, Anton SF, Merinkagas KR, Rounsaville BJ. Vulnerability to substance abuse and psychopathology among siblings of opioid abusers. J Nerv Ment Dis 1992;180:153-61.
56. Bellodi L, Battaglia M, Migone P. Disturbo di personalità antisociale. In: Cassano GB, Pancheri P, Pavan L, Pazzagli A, Ravizza L, Rossi R, Smeraldi E, Volterra V (Ed.). Trattato Italiano di Psichiatria. Milano: Masson; 1993. p. 1997-2002.
57. Zanarini HC, Gunderson JC, FRaenkenberg F.R. Axis II phenomenology of boderline personality disorder. Compr Psychiatry 1989;30:149-56.
58. Windle M. The difficult temperament in adolescence: associations with substance use, family support, and problem behaviors. J Clin Psychol 1991;47(2):310-5.
59. Altermann AI, Gerstley LJ, Strohmez DB, McKay JR. Psychiatric heterogeneity in antisocial alcoholics:relation to familiar alcoholism. Compr Psychiatry 1991;32(5):423-30.
60. Howard MO, Kivlahan D, Walker RD. Cloninger's tridimensional theory of personality and psychopathology: applications to substance use disorders. J Stud Alcohol 1997;58(1):48-66.
61. Mehrabian A, O'Reilly E. Personality correlates of habitual alcohol use. Int J Addict 1988;23(2):175-82.
62. Bernstein DP, Cohen P, Skodol AE, Beziganian S, Brook JS. Childhood antecedents of adolescent personality disorders. Am J Psychiatry 1996;153:907-13.
63. Zuckermann M. Sensation seeking, risk taking and health. In: Janisse MP (Ed.). Individual differences, stress and health. New York (NY): Springer-Verlag; 1988. p. 72-88.
64. Cloninger CR. A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry 1987;44:573-88.
65. Cloninger CR, Przybeck TR, Svrakic DM. The tridimensional personality questionnaire: US normative data. Psychol Rep 1991;69:1047-57.
66. Zuckermann M. Sensation seeking: beyond the optimal level of arousal. Helesdale NJ: Erlboum; 1979.
67. Benjamin JLiL, Patterson C., Greenberg BD, Murphy DL, Homer DH. Population and familiar association between D4 dopamine receptor gene and measures of NS. Nat Genet 1996;2(1):81-4.
68. Gerra G, Zaimovic A, Timpano M, Zambelli U, Delsignore R, Brambilla F. Neuroendocrine correlates of temperamental traits in humans. Psychoneuroendocrinology 2000;25(5):479-96.
69. Extein I, Pottash ALC, Gold MS. A possible opioid receptor dysfunction in some depressive disorders. In: Verebey K (Ed). Opioids in mental illness: theories, clinical observations and treatment possibilities. New York: The New York Academy of Sciences; 1982. (Ann NY Acad, 398).
70. Verebey K. Opioids in mental illness: theories, clinical observations and treatment possibilities. New York: The New York Academy of Sciences; 1982.
71. Zuckerman M, Neeb M. Sensation seeking and psychopathology. Psychiatry Res 1979;1(3):255-64.
72. Liraud F, Verdoux H. Which temperamental characteristics are associated with substance use in subjects with psychotic and mood disorders? Psychiatry Res 2000;93(1):63-72.
73. Block J, Block JH, Keyes S. Longitudinally foretelling drug usage in adolescence: early childhood personality and environmental precursors. Child Dev 1988;59:336-55.
74. Office of Substance Abuse prevention. Prevention plus. Rockville, MD; OSAP; 1989.
75. Babor TF, Wolson A, Boivin D. Alcoholism, culture and psychopathology: a compareative study of french, french canadian and american alcoholics. In: Helzer JE, Canino GH (Ed.). Alcoholism in North America, Europe and Asia. New York: Oxford University Press; 1992. p. 182-95.
76. Helzer JE, Canino HJ, Yeh E. Alcoholism-North America and Asia: a comparison of population surveys with the diagnostic interview schedule. Arch Gen Psychiatry 1990;47:313-9.
77. Grund JPC. Drug use as a social ritual: functionality, symbolism and determinants of self-regulation. Rotterdam: IVO Series; 1993.
78. O'Brien CP, Nace EP, Mintz J, Meyers AL, Ream N. Follow up of Vietnam Veterans, Relapse to drug use after Vietnam Service. Drug Alcohol Depend 1980;5:333-40.
79. Maremmani I, Zolesi O. Craving. Pisa: Pacini Editore Medicina; 1998.
80. Martin WR, Jasinski DR. Physiological parameters of morphine dependence in man, early abstinence, protracted abstinence. J Psychiatr Res 1969;7:9-17.
81. Martin WR. Pathophysiology of narcotic addiction: possible role of protracted abstinence in relapse. In: Zarafonetis CJD (Ed.). Drug abuse. Philadelphia: Lea and Febiger; 1972. p. 153-9.
82. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 1985;142:1259-64.
83. Woody GE, McLellan AT, Luborsky L. Sociopathy and psychotherapy outcome. Arch Gen Psychiatry 1985;42:1081-6.
84. Rounsaville BJ, Weissman MM, Crits-Chrispoph K, Wilher K, Kleber HB. Diagnosis and symptoms of depression in opiate addicts. Arch Gen Psychiatry 1982;39:151-6.
85. Silvestrini B. Malati di droga. Le sostanze d'abuso; danni fisici e psichici, reazione individuale, difese. Milano: Sperling e Kupfer; 1995.
86. Cannon DS, Rubin A, Keefe CK, Black JL, Leeka JK, Phillips LA. Affective correlates of alcohol and cocaine use. Addict Behav 1992;17(6):517-24.
87. Satel SL, Edell WS. Cocaine-induced paranoia and psychosis proneness. Am J Psychiatry 1991;148:1708-11.
88. Naditch MP. Acute adverse reaction to psychoactive drugs, drug use and psychopathology. J Abnorm Psychol 1974;83:394-403.
89. Fabian WD, Fishkin SM. Psychological absorption: affect investment in marijuana intoxication. J Nerv Merit Dis 1991;179:39-43.
90. DeWit H, Uhlenhuth EH, Pierri J, Johanson CE. Individual differences in behavioral and subjective responses to alcohol. Alcohol Clin Exp Res 1987;11:52-9.
91. Labouvie EW. Personality and alcool and marijuana use: patterns of convergence in young adulthood. Int J Addict 1990;25(3):237-52.
92. Fischman MW, Foltin RW. Self-administration of cocaine for humans: a laboratory perspective. In: Fischman MW, Foltin RW (Ed.). Cocaine: scientific and social dimensions. New York: John Wiley & Sons; 1992. p. 165-80.
93. Vaillant GE. The natural history of alcoholism: causes, patterns, and paths to recovery. Cambridge: Mass. Harvard University Press; 1983.
94. Beck AT, Wright FD, Newman CF, Liese BS. Cognitive therapy of substance abuse. New York (NY): Guilford Press; 1993.
95. Kuhar MJ. Molecular pharmacology of cocaine: a dopamine hypothesis and its implications. Lousanne: Ciba-Geigy; 1992.
96. Woolverton WL. Determinants of cocaine self-administration by laboratory animals. Lousanne: Ciba-Geigy; 1992.
97. McLellan AT, Luborsky L, Woody GE, Druley KA, O'Brien CP. Predicting response to alcohol and drug abuse treatments: role of psychiatric severity. Arch Gen Psychiatry 1983;40:620-5.
98. McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP. The effects of psychological services in substance abuse treatment. JAMA 1993;269:1953-9.
99. McLellan AT. "Psychiatric severity" as a predictor of outcome from substance abuse treatments. In: Meyer RE (Ed.). Psychopathology and addictive disorders. New York: Guilford Press; 1986.
100. Rounsaville BJ, Weissman MM, Kleber H, Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch Gen Psychiatry 1982;39:161-6.
101. Hesselbrock MN, Meyer RE, Keener JJ. Psychopathology in hospitalized alcoholics. Arch Gen Psychiatry 1985;42:1050-5.
102. Penick EC, Powell BJ, Liskow B, Jackson JO, Nickel EJ. The stability of coexisting psychiatric syndromes in alcoholic men after one year. J Stud Alcohol 1988;49:395-405.
103. Wieland WF, Sola S. Depression in opiate addicts measured by objective tests. Proceedings of the III National Conference on Methadone Treatment. New York: AMTA; 1970. p. 187-202.
104. Lehman WX, De Angelis GC. Adolescents, methadone, and psychoterapeutic agents. Proceedings of the Fourth National Conference on Methadone Treatment. New York: National Association for the Prevention of the Addiction to Narcotics; 1972. p. 95-104.
105. Robins PR. Depression and drug addiction. Psychoanal Q 1974;48:375-86.
106. Weissman MM, Slobetz F, Prusoff BA, Mesritz M, Howard PAT. Clinical depression among narcotic addicts maintained on methadone in the community. Am J Psychiatry 1976;133:1434-8.
107. Senay EC. Multimodality programming in Illinois: evolution of a public health concept. In: Lowinson JH, Ruiz P (Ed.). Substance abuse. Clinical problem and perspectives. Baltimore ML: Williams and Wilkins; 1981. p. 365-82.
108. Rounsaville BJ, Weissman MM, Rosenberger PH, Wilbur CH, Kleber HD. Detecting depressive disorders in drug abusers: a comparison of screening instruments. J Affect Disord 1979;1:255-67.
109. Steer RA, Kotzer E. Affective changes in male and female methadone patients. Drug Alcohol Depend 1980;5:115-22.
110. McLellan AT, O'Brien CP, Kron R, Druley KA, Alderman AI. Matching substance abuse patients to appropriate treatments. Drug Alcohol Depend 1980 5(3):189-95.
111. Hendriks WJ. Use of multifamily counseling groups in treatment of male narcotics addicts. Int J Group Psychother 1971;21:34-90.
112. Jainchill N, De Leon G, Pinkham L. Psychiatric diagnosis among substance abusers in therapeutic community treatment. J Psychoactive Drugs 1986;18/3:209-13.
113. Khantzian EJ, Treece CD. Heroin addiction: the diagnostic dilemma for Psychiatry. In: Pickens RW, Heston LL (Ed.). Psychiatric factors in drug abuse. New York (NY): Grune and Stratton; 1979. p. 21-45.
114. O'Doherty F, Davies JB. Life events and addiction: a critical review. Br J Addict 1987;82/2:127-37.
115. Woody GE, McLellan AT, Luborsky L, O'Brien CP. Psychiatric severity as a predictor of benefits from psychotherapy: The Penn-VA study. Am J Psychiatry 1984;141:1172-7.
116. Inman DJ, Bascue LO, Scoloda T. Identifications of borderline personality disorders among substance abuse in-patients. J Subst Abuse Treat 1985;2/4:229-32.
117. Pope HG. Drug abuse and psychopatology. N Engl J Med 1979;301/24:1341-2.
118. Humeniuk R, Ali R, White J, Hall W, Farrel M. Proceedings of the expert workshop on induction and stabilisation of patients onto methadone. Adelaide: NIDA; 2000.
119. De Jong AJ, Van Den Brink W, Hartveld FM. Personality disorders in alcoholics and drug addicts. Compr Psychiatry 1996;34(2):87-94.
120. Dackis CA, Gold MS. Opiate addiction and depression. Cause or effect. Drug Alcohol Depend 1983;11:105-9.
121. Clerici M, Capitanio C, Garini R, Carta I. Tossicodipendenza ed interventi psicoterapeutici: Il profilo psicopathogico del tossicodipendente da eroina. Arch Psicol Neurol Psichiat 1987; 48:546-59.
122. Mintz J, O'Brien CP, Woody GE, Beck AT. Depression in treated narcotic addicts, ex addicts, non addicts, and suicide attempters: Validation of a very brief depression scale. Am J Drug Alcohol Abuse 1979;6:385-96.
123. Pilowsky I, Katsikitis M. Depressive illness and dependency. Acta Psychiatr Scand 1983;68:11-4.
124. Rounsaville BJ, Weissman MM, Crits-Christoph K, Wilber CH, Kleber HB. Diagnosis and symptoms of depression in opiate addicts: Course and relationship to treatment outcome. Arch Gen Psychiatry 1982;39:156-61.
125. Shaw BF, Steer RA, Beck AT, Schut J. Structure of depression in heroin addicts. Br J Addict 1979;74:295-303.
126. Bela GLA, Folke J, Von Knorring L, Terenius L, Wahlstrom A. Endorphins in chronic pain. Differences in CSF endorphin levels between organic and psychogenic pain syndromes. Pain 1978;5:153-62.
127. Woody GE, Blaine JD. Depression in narcotic addicts: Quite possibly more than a chance association. In: Dupont RL, Goldstein A, O'Donnell J (Ed.). Handbook on drug abuse. Washington, DC: US Govt. Print. Off.; 1979. (National Institute on Drug Abuse Pub, 277-286).
128. Khantzian EJ. Psychoterapeutic interventions with substance abusers: the clinical contest. J Subst Abuse Treat 1985;2(2):83-8.
129. Rounsaville BJ, Rosenberger PH, Wilber CH, Weissman MM, Kleber HB. A comparison of the SAD/RDC and the DSM-III. Diagnosing drug abusers. J Nerv Ment Dis 1980;168:90-7.
130. Rounsaville BJ, Cacciola J, Weissman MM, Kleber HD. Diagnostic concordance in a follow-up study of opiate addicts. J Psychiatr Res 1981;16:191-201.
131. Rounsaville BJ, Weissman MM, Wilber CH, Kleber HD. The heterogeneity of psychiatry disorders in treated opiate addicts. Arch Gen Psychiatry 1982;39:161-6.
132. Rounsaville BJ, Weissman MM, Kleber HD. An evaluation of depression in opiate addicts. Res Commun Ment Health 1983;3:257-89.
133. Rounsaville BJ, Eyre S, Weissman MM, Kleber HD. The antisocial opiate addict. Adv Alcohol Substance Abuse 1983;2:29-42.
134. Rounsaville BJ. Epidemiology of drug use and abuse in adults. In: Cavenar JO (Ed.). Psychiatry. New York: Basic Books Inc; 1985. p. 137-43.
135. Rounsaville BJ, Kosten TR, Weissman MM, Kleber HD. Evaluating and treating depressive disorders in opiate addicts. Rockville, MD: NIDA National Institute on Drug Abuse; 1985.
136. Rounsaville BJ, Kleber HD. Psychiatric disorders in opiate addicts: preliminary findings on the cause and interaction with program type. In: Meyer RE (Ed.). Psychopathology and addictive disorders. New York: Guilford; 1986. p. 140-68.
137. Rounsaville BJ, Kosten TR, Kleber HD. Long-term changes in current psychiatric diagnoses of treated opiate addicts. Compr Psychiatry 1986;27:480-98.
138. Rounsaville BJ, Dolinsky ZS, Babor TF, Meyer RE. Psychopathology as a predictor of treatment outcome in alcoholics. Arch Gen Psychiatry 1987;44:505-13.
139. Mirin SN, Weiss RD, Griffin ML, Michael JL. Psychopathology in drug abusers and their families. Compr Psychiatry 1991;32:36-51.
140. Mirin SM, Weiss R, Michael J, Griffin M. Psychopathology in substance abusers: Diagnosis and treatment. Am J Drug Alcohol Abuse 1988;14(2):139-57.
141. Mirin SM, Weiss RD. Psychiatric comorbidity in drug/alcohol addiction. In: Miller NS (Ed). Comprehensive handbook of drug and alcohol addiction. White Plains, New York: Mercel Dekker, Inc; 1991. p. 65-77.
142. Volovka SJ, Anderson B, Koz G. Naloxone and naltrexone in mental illness and tardive dyskinesia. In: Verebey K (Ed). Opioids in mental illness: theories, clinical observations and treatment possibilities. New York: The New York Academy of Sciences; 1982. (Ann NY Acad, 398). p. 143-52.
143. Milkman H, Frosch W. On the preferential abuse of heroin and amphetamines. J Nerv Ment Dis 1973;156(4):242-8.
144. Castaneda R, Galanter M, Franco H. Self-medication among addicts with primary psychiatric disorders. Compr Psychiatry 1989;30:80-3.
145. Khantzian EJ. Opiate addiction: A critique of theory and some implications for treatment. Am J Psychother 1974;28:59-70.
146. Wurmser L. Psychoanalytic considerations of the etiology of compulsive drug abuse. Am Psychoanal Ass 1974;22:820-43.
147. Maremmani I, Zolesi O, Aglietti M, Marini G, Tagliamonte A, Shinderman M, Maxwell S. Methadone dose and retention in treatment of heroin addicts with axis I psychiatric comorbidity. J Addict Dis 2000;19(2):29-41.
148. Himmelhoch JM, Mulla D, Neil JF, Detre TP, Kupfer DJ. Incidence and significance of mixed affective states in a bipolar population. Arch Gen Psychiatry 1976;33:1062-7.
149. Brady KT, Sonne SC. The relationship between substance abuse and bipolar disorder. J Clin Psychiatry 1995;56(3):19-24.
150. Winokur G, Coryell W, Akiskal HS, Maser J, Keller MB, Endicott J, Mueller T. Alcoholism in manic-depressive (bipolar) illness: familial illness, course of illness and the primary-secondary distinction. Am J Psychiatry 1995;152:365-72.
151. Maremmani I, Capone MR, Aglietti M, Castrogiovanni P. Heroin dependence and Bipolar Disorders. New Trends Exper Clin Psychiatry 1994;X:179-82.
152. Martin WR, Jasinski DR, Mansky PA. Naltrexone, an antagonist for the treatment of heroin dependence. Arch Gen Psychiatry 1973;28:784-91.
153. Sideroff SN, Charauwasta VC, Farvik ME. Craving in heroin addicts maintained on the opiate antagonist Naltrexone. Am J Drug Alcohol Abuse 1978;5:415-23.
154. Resnick RB, Schuyten E, Cooper L, Schwartz L. Narcotic antagonists: a point of view concerning treatment approaches. Rokville: NIDA; 1974.
155. Pacini M. Personalità, temperamento e uso di sostanze. Revisione della letteratura e contributo sperimentale. Università di Pisa: Tesi di Laurea in Medicina; 1998-1999.
156. Maremmani I, Lazzeri A, Canoniero S, Aglietti M, Placidi GF. Abuso di sostanze e psicosi croniche. Giorn Ital Psicopat 1999;5(3):290-303.
157. Perugi G, Frare F, Madaro D, Maremmani I, Akiskal HS. Alcohol abuse in social phobic patients: is there a bipolar connection? J Affect Disord 2002;68(1):33-9.
158. Perretta P, Akiskal HS, Nisita C, Lorenzetti C, Zaccagnini E, Della Santa M, Cassano GB. The high prevalence of bipolar II and associated cyclothymic and hyperthymic temperaments in HIV-patients. J Affect Disord 1998;50(2-3):215-24.
159. Akiskal HS. Subaffective disorders: dysthymic, cyclothymic and bipolar II disorders in the 'borderline' realm. Psychiatr Clin North Am 1981;4:25-46.
160. Akiskal HS, Choen SE, Davis GC, Punzantian VR, Kashgarian M, Bolinger JM. Borderline: an adjective in search of the name. J Clin Psychiatry 1985;46:41-8.